Neodymium:YAG visual laser ablation of the prostate
OBJECTIVE: This study was performed to evaluate safety and efficacy of laser prostatectomy in the treatment of symptomatic benign prostatic hyperplasia (BPH).
METHODS: Neodymium:yttrium-aluminum-garnet (YAG) visual laser ablation of the prostate was performed in 43 patients (mean age 66 +/- 11.5 years) with BPH. The mean prostatic volume was 44.7 +/- 19.7 ml. A right-angle, side-firing laser fiber (Lasersonics Ultraline) and a neodymium:YAG laser generator (Hercules 5060) were used.
RESULTS: There were no perioperative complications including hemorrhage and transurethral reflux syndrome. The average postoperative hospital stay was 1.3 days, and the average urethral catheterization time was 3.8 days. Thirty-two patients were evaluated 6 months after the operation. A significant improvement was found in the mean symptom score from 21.8 +/- 7.6 to 8.3 +/- 6.9 (p < 0.001). A significant decrease from 104.3 +/- 78 to 55.7 +/- 30 ml was found between the preoperative and the postoperative mean residual urine volumes (p < 0.001). The mean peak flow rate increased from 8.7 +/- 3.9 to 16.1 +/- 2.4 ml/s (p < 0.001), and the mean average flow rate increased from 4.9 +/- 2 to 10.2 +/- 2.9 ml/s (p < 0.001).
CONCLUSION: Our results indicate that laser prostatectomy is a promising alternative in the treatment of BPH.
Medienart: |
Artikel |
---|
Erscheinungsjahr: |
1996 |
---|---|
Erschienen: |
1996 |
Enthalten in: |
Zur Gesamtaufnahme - volume:29 |
---|---|
Enthalten in: |
European urology - 29(1996), 4 vom: 29., Seite 446-9 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Sengör, F [VerfasserIn] |
---|
Themen: |
---|
Anmerkungen: |
Date Completed 20.11.1996 Date Revised 26.08.2019 published: Print Citation Status MEDLINE |
---|
Förderinstitution / Projekttitel: |
|
---|
PPN (Katalog-ID): |
NLM087624710 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM087624710 | ||
003 | DE-627 | ||
005 | 20231222072128.0 | ||
007 | tu | ||
008 | 231222s1996 xx ||||| 00| ||eng c | ||
028 | 5 | 2 | |a pubmed24n0292.xml |
035 | |a (DE-627)NLM087624710 | ||
035 | |a (NLM)8791052 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Sengör, F |e verfasserin |4 aut | |
245 | 1 | 0 | |a Neodymium:YAG visual laser ablation of the prostate |
264 | 1 | |c 1996 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ohne Hilfsmittel zu benutzen |b n |2 rdamedia | ||
338 | |a Band |b nc |2 rdacarrier | ||
500 | |a Date Completed 20.11.1996 | ||
500 | |a Date Revised 26.08.2019 | ||
500 | |a published: Print | ||
500 | |a Citation Status MEDLINE | ||
520 | |a OBJECTIVE: This study was performed to evaluate safety and efficacy of laser prostatectomy in the treatment of symptomatic benign prostatic hyperplasia (BPH) | ||
520 | |a METHODS: Neodymium:yttrium-aluminum-garnet (YAG) visual laser ablation of the prostate was performed in 43 patients (mean age 66 +/- 11.5 years) with BPH. The mean prostatic volume was 44.7 +/- 19.7 ml. A right-angle, side-firing laser fiber (Lasersonics Ultraline) and a neodymium:YAG laser generator (Hercules 5060) were used | ||
520 | |a RESULTS: There were no perioperative complications including hemorrhage and transurethral reflux syndrome. The average postoperative hospital stay was 1.3 days, and the average urethral catheterization time was 3.8 days. Thirty-two patients were evaluated 6 months after the operation. A significant improvement was found in the mean symptom score from 21.8 +/- 7.6 to 8.3 +/- 6.9 (p < 0.001). A significant decrease from 104.3 +/- 78 to 55.7 +/- 30 ml was found between the preoperative and the postoperative mean residual urine volumes (p < 0.001). The mean peak flow rate increased from 8.7 +/- 3.9 to 16.1 +/- 2.4 ml/s (p < 0.001), and the mean average flow rate increased from 4.9 +/- 2 to 10.2 +/- 2.9 ml/s (p < 0.001) | ||
520 | |a CONCLUSION: Our results indicate that laser prostatectomy is a promising alternative in the treatment of BPH | ||
650 | 4 | |a Journal Article | |
700 | 1 | |a Erdoğan, K |e verfasserin |4 aut | |
700 | 1 | |a Tuzluoğlu, D |e verfasserin |4 aut | |
700 | 1 | |a Onur, S |e verfasserin |4 aut | |
700 | 1 | |a Erol, A |e verfasserin |4 aut | |
700 | 1 | |a Sözer, T |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t European urology |d 1977 |g 29(1996), 4 vom: 29., Seite 446-9 |w (DE-627)NLM000137588 |x 1873-7560 |7 nnns |
773 | 1 | 8 | |g volume:29 |g year:1996 |g number:4 |g day:29 |g pages:446-9 |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 29 |j 1996 |e 4 |b 29 |h 446-9 |